Skip to content

Ultrasound Guided Intermediate Cervical Plexus Block for Congenital Muscular Torticollis

Randomized Controlled Trial of the Postoperative Analgesic Efficacy of Ultrasound Guided Intermediate Cervical Plexus Block for Unipolar Sternocleidomastoid Release in Patient With Congenital Muscular Torticollis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02651311
Enrollment
32
Registered
2016-01-11
Start date
2016-01-16
Completion date
2016-12-15
Last updated
2017-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Muscular Torticollis

Brief summary

Congenital Muscular Torticollis (CMT) is a postural deformity of head and neck detected at birth or shortly after birth, primarily resulting from unilateral shortening of Sternocleidomastoid Muscle (SCM). Surgery could be chosen for the treatment for some children, which is accompanied by moderate pain and discomfort. The investigators focused the effectiveness of intermediates cervical plexus block because the dermatome of sensory of cervical plexus block is correlated to that of torticollis. So the effect of analgesia could decrease the use of analgesics.

Interventions

ultrasound guided intermediate cervical plexus block with 0.25% ropivacaine 0.2 ml/kg

DRUGFentanyl

fentanyl 0.5 µg/kg in postanesthetic care unit when more or equal to FLACC scale 4.

DRUGIbuprofen

ibuprofen in ward when more or equal to FLACC scale 4.

Sponsors

Ajou University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-II * Undergoing general anesthesia for unipolar sternocleidomastoid release in patient with congenital muscular torticollis

Exclusion criteria

* coagulation disorder * kidney or liver disease * allergy to local anesthetics

Design outcomes

Primary

MeasureTime frame
Pain on the FLACC scaleat 5 min after postanesthesia care unit admission

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026